amoxicillin
Amoxicillin is a broad-spectrum penicillin antibiotic that stops bacteria from building their cell walls. It is used for common bacterial infections such as pneumonia and skin, ear and urinary tract infections, and with other medicines to eliminate Helicobacter pylori in ulcer disease.
This page is based on MedlinePlus drug information for amoxicillin, cross-checked with the National Cancer Institute dictionary; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
A bacterium is like a balloon held in shape by a woven net. As it grows, it constantly stitches new mesh into the net. Amoxicillin jams the stitching machine, so the net stays full of holes; the balloon keeps swelling inside and eventually pops.
In simple terms
Bacteria need a strong outer wall to survive, and they build it with the help of enzymes called penicillin-binding proteins. Amoxicillin attaches to those enzymes and switches them off, so the wall can no longer be stitched together. Weakened, the bacterium breaks apart as it tries to grow. Human cells have no such wall, which is why the medicine targets bacteria selectively.
In depth
Amoxicillin is a semisynthetic aminopenicillin that acylates the active-site serine of penicillin-binding proteins, notably PBP1A, on the inner bacterial membrane. This blocks the transpeptidation step of peptidoglycan synthesis, preventing cross-linking of glycan strands and triggering autolysin-mediated cell lysis. It is bactericidal against susceptible gram-positive and some gram-negative organisms and is well absorbed orally.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How amoxicillin blocks peptidoglycan cross-linking
- Bacteria need a strong outer wall to survive, and they build it with the help of enzymes called penicillin-binding proteins.
- Amoxicillin is a semisynthetic aminopenicillin that acylates the active-site serine of penicillin-binding proteins, notably PBP1A, on the inner bacterial membrane.
- This blocks the transpeptidation step of peptidoglycan synthesis, preventing cross-linking of glycan strands and triggering autolysin-mediated cell lysis.
- It is bactericidal against susceptible gram-positive and some gram-negative organisms and is well absorbed orally.
Target: Penicillin-binding protein 1A (PBP1A)
A bacterial enzyme that cross-links the peptidoglycan mesh of the cell wall; without its activity the wall weakens and the bacterium bursts.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Treatment of infections caused by susceptible bacteria, including pneumonia and skin and urinary tract infections
- In combination with other medicines, to eliminate Helicobacter pylori, the bacterium that causes stomach ulcers
Official sources
The statements on this page trace back to these records.
- MedlinePlus: amoxicillin
MedlinePlus, U.S. National Library of Medicine
- National Cancer Institute: amoxicillin
National Cancer Institute
- Emc SmPC: amoxicillin (UK licensed product)
Medicines and Healthcare products Regulatory Agency (EMC)
- Health Canada: amoxicillin product information
Health Canada
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.